WO2004106941A3 - Secreted polypeptide species associated with cardiovascular disorders - Google Patents
Secreted polypeptide species associated with cardiovascular disorders Download PDFInfo
- Publication number
- WO2004106941A3 WO2004106941A3 PCT/EP2004/005786 EP2004005786W WO2004106941A3 WO 2004106941 A3 WO2004106941 A3 WO 2004106941A3 EP 2004005786 W EP2004005786 W EP 2004005786W WO 2004106941 A3 WO2004106941 A3 WO 2004106941A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cardiovascular disorders
- secreted polypeptide
- species associated
- polypeptide species
- polypeptides
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006529944A JP2007513063A (en) | 2003-05-30 | 2004-05-28 | Secreted polypeptide species associated with cardiovascular disorders |
EP04735211A EP1634086A2 (en) | 2003-05-30 | 2004-05-28 | Secreted polypeptide species associated with cardiovascular disorders |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47508203P | 2003-05-30 | 2003-05-30 | |
US47508303P | 2003-05-30 | 2003-05-30 | |
US47512103P | 2003-05-30 | 2003-05-30 | |
US60/475,121 | 2003-05-30 | ||
US60/475,082 | 2003-05-30 | ||
US60/475,083 | 2003-05-30 | ||
US48410203P | 2003-06-30 | 2003-06-30 | |
US60/484,102 | 2003-06-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004106941A2 WO2004106941A2 (en) | 2004-12-09 |
WO2004106941A3 true WO2004106941A3 (en) | 2005-05-26 |
Family
ID=33494283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/005786 WO2004106941A2 (en) | 2003-05-30 | 2004-05-28 | Secreted polypeptide species associated with cardiovascular disorders |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1634086A2 (en) |
JP (1) | JP2007513063A (en) |
WO (1) | WO2004106941A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6835545B2 (en) | 2000-05-08 | 2004-12-28 | President And Fellows Of Harvard College | Methods, products and treatments for diabetes |
US7439330B2 (en) | 2000-05-08 | 2008-10-21 | President And Fellows Of Harvard College | Anti-glycated CD59 antibodies and uses thereof |
FI118265B (en) * | 2004-01-15 | 2007-09-14 | Jurilab Ltd Oy | A method for detecting the risk of acute myocardial infarction and coronary heart disease |
US7833725B2 (en) | 2005-01-06 | 2010-11-16 | President And Fellows Of Harvard College | Mass spectrometric methods and products |
US8238515B2 (en) * | 2007-08-16 | 2012-08-07 | Caldera Pharmaceuticals, Inc. | Well plate |
JP5318874B2 (en) * | 2007-09-10 | 2013-10-16 | ジーイー・ヘルスケア・リミテッド | Radiofluorination method |
WO2012027555A2 (en) | 2010-08-25 | 2012-03-01 | President And Fellows Of Harvard College | Glycated cd59 peptides, their preparation, and uses thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5641497A (en) * | 1992-05-22 | 1997-06-24 | Children's Hospital Of Philadelphia | Gastrointestinal defensins, cDNA sequences and method for the production and use thereof |
WO2001030354A1 (en) * | 1999-10-26 | 2001-05-03 | Thomas Jefferson University | REGULATION OF Apob FOR DIAGNOSIS, TREATMENT AND DRUG SCREENING FOR CARDIOVASCULAR AND METABOLIC DISORDERS OR SYNDROMES |
-
2004
- 2004-05-28 WO PCT/EP2004/005786 patent/WO2004106941A2/en not_active Application Discontinuation
- 2004-05-28 JP JP2006529944A patent/JP2007513063A/en active Pending
- 2004-05-28 EP EP04735211A patent/EP1634086A2/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5641497A (en) * | 1992-05-22 | 1997-06-24 | Children's Hospital Of Philadelphia | Gastrointestinal defensins, cDNA sequences and method for the production and use thereof |
WO2001030354A1 (en) * | 1999-10-26 | 2001-05-03 | Thomas Jefferson University | REGULATION OF Apob FOR DIAGNOSIS, TREATMENT AND DRUG SCREENING FOR CARDIOVASCULAR AND METABOLIC DISORDERS OR SYNDROMES |
Non-Patent Citations (2)
Title |
---|
HIGAZI ABD AL-ROOF ET AL: "Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells", BLOOD, vol. 89, no. 12, 1997, pages 4290 - 4298, XP002299296, ISSN: 0006-4971 * |
TANG YI-QUAN ET AL: "Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes", INFECTION AND IMMUNITY, vol. 67, no. 11, November 1999 (1999-11-01), pages 6139 - 6144, XP002299297, ISSN: 0019-9567 * |
Also Published As
Publication number | Publication date |
---|---|
WO2004106941A2 (en) | 2004-12-09 |
EP1634086A2 (en) | 2006-03-15 |
JP2007513063A (en) | 2007-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003101401A3 (en) | Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer | |
WO2004047755A3 (en) | Fused bicyclic nitrogen-containing heterocycles | |
ZA200701656B (en) | Humanized anti-cment antagonists | |
WO2004098377A3 (en) | Methods and compositions for diagnosis and therapy of parkin-associated disorders | |
WO2006068987A3 (en) | Uses of il-23 antagonists in the treatment of diabetes mellitus | |
WO2002060317A3 (en) | Compositions and methods for the therapy and diagnosis of pancreatic cancer | |
WO2007059135A3 (en) | Methods of treating alzheimer's disease | |
WO2002074156A8 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
WO2003087831A3 (en) | Proteins involved in breast cancer | |
ZA200500882B (en) | Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis of treatment or liver disorders and epithelial cancer | |
WO2002092001A3 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
WO2003104425A3 (en) | Novel stable anti-cd22 antibodies | |
WO2004002431A3 (en) | Humanized anti-lymphotoyin beta receptor antibodies | |
WO2005014635A3 (en) | Secreted polypeptide species reduced in cardiovascular disorders | |
WO2005015206A3 (en) | Secreted polypeptide species associated with cardiovascular disorders | |
GB0124145D0 (en) | Genes and proteins for prevention,prediction,prognosis and therapy of cardiovascular disease | |
WO2003037267A8 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
WO2005030793A3 (en) | Antibodies which bind human cxcr3 | |
WO2004106941A3 (en) | Secreted polypeptide species associated with cardiovascular disorders | |
WO2004090551A3 (en) | Secreted polypeptide species associated with cardiovascular disorders | |
WO2004083241A3 (en) | Btc-interacting proteins and use thereof | |
WO2004047757A3 (en) | Diagnosing and treating hematopoietic cancers | |
WO2006029838A3 (en) | Secreted polypeptide species involved in alzheimer’s disease | |
WO2005037236A3 (en) | Novel heat shock protein 20-related polypeptides and uses therefor | |
WO2005003781A3 (en) | Secreted polypeptide species associated with cardiovascular disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004735211 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006529944 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004735211 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2004735211 Country of ref document: EP |